The Etiological and Drug Resistance Characteristics of Multidrug-Resistant Pathogens in Patients Requiring Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study

References

• Angel ND, Amir MM, Naomi H, et al. Antimicrobial resistance and human mobility. Infect Drug Resist. 2022;15:127–133.
   PubMed Web of Science ®Google Scholar
• Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903–3910. doi:10.2147/IDR.S234610
   PubMed Web of Science ®Google Scholar
• Ying Z, Wei EH, Qiwen Y. Clinical perspective of antimicrobial resistance in bacteria. Infect Drug Resist. 2022;15:735–746.
   PubMed Web of Science ®Google Scholar
• Gowri R, Esther EA, Jeffrey C, et al. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:79. doi:10.1186/s13756-018-0370-9
   PubMed Web of Science ®Google Scholar
• Palacios-Baena ZR, Giannella M, Manissero D, et al. Risk factors for carbapenem-resistant gram-negative bacterial infections: a systematic review. Clin Microbiol Infect. 2021;27(2):228–235. doi:10.1016/j.cmi.2020.10.016
   PubMed Web of Science ®Google Scholar
• Schweickhardt SK, Sams VG, Radowsky JS, et al. Infections complicating extracorporeal membrane oxygenation in patients with traumatic injuries. Injury. 2023;54(2):405–408. doi:10.1016/j.injury.2022.11.048
   PubMed Web of Science ®Google Scholar
• Boscolo A, Sella N, Pettenuzzo T, et al. Multidrug-resistant and extended-spectrum β-lactamase gram-negative bacteria in bilateral lung transplant recipients: incidence, risk factors, and in-hospital mortality. Chest. 2022;162(6):1255–1264. doi:10.1016/j.chest.2022.06.046
   PubMed Web of Science ®Google Scholar
• Petros IR, Diamantis K. Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria. Expert Rev Anti Infect Ther. 2022;20(2):139–146. doi:10.1080/14787210.2021.1945922
   PubMed Web of Science ®Google Scholar
• Romney H, April MB, Janet AH, et al. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st edition. J Clin Microbiol. 2021;59(12):e0021321. doi:10.1128/JCM.00213-21
   PubMed Web of Science ®Google Scholar
• Xiyuan L, Liangshan W, Hong W, et al. Outcome and clinical characteristics of nosocomial infection in adult patients undergoing extracorporeal membrane oxygenation: a systematic review and meta-analysis. Front Public Health. 2022;10:857873. doi:10.3389/fpubh.2022.857873
   PubMed Web of Science ®Google Scholar
• Bouglé A, Bombled C, Margetis D, et al. Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: epidemiology and risk factors of treatment failure. PLoS One. 2018;13(4):e0194976. doi:10.1371/journal.pone.0194976
   PubMed Web of Science ®Google Scholar
• Simona S, Marco R, Valeria P, et al. Bloodstream infections during post-cardiotomy extracorporeal membrane oxygenation: incidence, risk factors, and outcomes. Int J Artif Organs. 2019;42(6):299–306. doi:10.1177/0391398818817325
   PubMed Web of Science ®Google Scholar
• Roman K, Alexey K. The dynamics of antimicrobial resistance among Enterobacteriaceae isolates in Russia: results of the 2012–2018 INFORM and ATLAS international program studies. Antibiotics. 2022;11(6):790. doi:10.3390/antibiotics11060790
   Google Scholar
• Teerawattanapong N, Kengkla K, Dilokthornsakul P, et al. Prevention and control of multidrug-resistant gram-negative bacteria in adult intensive care units: a systematic review and network meta-analysis. Clin Infect Dis. 2017;64(Suppl suppl_2):S51–S60. doi:10.1093/cid/cix112
   PubMedGoogle Scholar
• JongHoon H, Sang Kil L, Jae Hee C, et al. Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms. Antimicrob Resist Infect Control. 2022;11(1):20. doi:10.1186/s13756-022-01064-4
   PubMed Web of Science ®Google Scholar
• Aya Y, Yoshihiko N, Shiho H, et al. The association between the oral-gut axis and the outcomes of severe COVID-19 patients receiving extracorporeal membrane oxygenation: a case-control study. J Clin Med. 2022;11(5):1167. doi:10.3390/jcm11051167
   PubMed Web of Science ®Google Scholar
• Giacomo G, Vittorio S, Laura A, et al. Gastrointestinal colonization with multidrug-resistant gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome. Ann Intensive Care. 2019;9(1):141. doi:10.1186/s13613-019-0615-7
   PubMed Web of Science ®Google Scholar
• Jessica T, Rafael Almeida DA, Nasia S. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control. 2016;44(5):539–543. doi:10.1016/j.ajic.2015.12.005
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik A, Rizvi M, Ahmed M, Singh A. Epidemiology of multidrug-resistant gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients. J Glob Antimicrob Resist. 2017;9:47–50. doi:10.1016/j.jgar.2016.12.016
   PubMed Web of Science ®Google Scholar
• Meštrović T. Antimicrobial resistance in Klebsiella pneumoniae as an independent risk factor for bacteraemia-related mortality. Hong Kong Med J. 2021;27(5):385. doi:10.12809/hkmj219773
   PubMed Web of Science ®Google Scholar
• Xiaohua Q, Shi W, Min H, et al. The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020;221(Suppl 2):S206–S214. doi:10.1093/infdis/jiz622
   PubMedGoogle Scholar
• Stephen MB, Daniel R, Peter K, et al. Trends in hospital-acquired and ventilator-associated bacterial pneumonia trials. Clin Infect Dis. 2021;73(3):e602–e608. doi:10.1093/cid/ciaa1712
   PubMed Web of Science ®Google Scholar
• Natalia B, Anthony DH, Clare R, et al. Risk factors and outcomes associated with multidrug-resistant Acinetobacter baumannii upon intensive care unit admission. Antimicrob Agents Chemother. 2017;62(1):e01631–e01617. doi:10.1128/AAC.01631-17
   PubMed Web of Science ®Google Scholar
• Evgeni B, Abraham B, Leonid K, et al. Multidrug resistance Acinetobacter bacteremia secondary to ventilator-associated pneumonia: risk factors and outcome. J Intensive Care Med. 2017;32(9):528–534. doi:10.1177/0885066616632193
   PubMed Web of Science ®Google Scholar
• Wenzhong P, Yanhao W, Rongli L, et al. Successful treatment of acute respiratory distress syndrome caused by hypervirulent Klebsiella pneumoniae with extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report and literature review. Front Med. 2022;9:936927. doi:10.3389/fmed.2022.936927
   Web of Science ®Google Scholar
• Karaiskos I, Lagou S, Pontikis K, et al. The “old” and the “new” antibiotics for MDR gram-negative pathogens: for whom, when, and how. Front Public Health. 2019;7:151. doi:10.3389/fpubh.2019.00151
   PubMed Web of Science ®Google Scholar
• Monsel A, Torres A, Yinggang Z, et al. Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials. Curr Opin Infect Dis. 2021;34(2):156–168. doi:10.1097/QCO.0000000000000720
   PubMed Web of Science ®Google Scholar
• Nguyen M, Joshi SG. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review. J Appl Microbiol. 2021;131(6):2715–2738. doi:10.1111/jam.15130
   PubMed Web of Science ®Google Scholar
• Swati S, Tuhina B, Ashok K, et al. Extensive outbreak of colistin resistant, carbapenemase (blaOXA-48, blaNDM) producing Klebsiella pneumoniae in a large tertiary care hospital, India. Antimicrob Resist Infect Control. 2022;11(1):1. doi:10.1186/s13756-021-01048-w
   PubMed Web of Science ®Google Scholar
• Yudong L, Qi W, Chunjiang Z, et al. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in Acinetobacter baumannii complex bacteraemia: experience from the Chinese antimicrobial resistance surveillance of nosocomial infections (CARES) network. J Med Microbiol. 2020;69(7):949–959. doi:10.1099/jmm.0.001222
   PubMed Web of Science ®Google Scholar
• Karaiskos I, Giamarellou H. Carbapenem-sparing strategies for ESBL producers: when and how. Antibiotics. 2020;9(2):61. doi:10.3390/antibiotics9020061
   Google Scholar
• Yuan T, QiaoYu Z, LiRong W, Jiansen C. Combined effect of polymyxin B and tigecycline to overcome heteroresistance in carbapenem-resistant Klebsiella pneumoniae. Microbiol Spectr. 2021;9(2):e0015221. doi:10.1128/Spectrum.00152-21
   PubMed Web of Science ®Google Scholar
• Yuan Z, Hongbin H, Qing Z, et al. Effects of ex vivo extracorporeal membrane oxygenation circuits on sequestration of antimicrobial agents. Front Med. 2021;8:748769. doi:10.3389/fmed.2021.748769
   Web of Science ®Google Scholar
• Čiginskienė A, Dambrauskienė A, Rello J, et al. Ventilator-associated pneumonia due to drug-resistant Acinetobacter baumannii: risk factors and mortality relation with resistance profiles, and independent predictors of in-hospital mortality. Medicina. 2019;55(2):49. doi:10.3390/medicina55020049
   PubMedGoogle Scholar
• Lei Z, Xue Z, Yusheng C, et al. Intravenous polymyxin B as adjunctive therapy to high-dose tigecycline for the treatment of nosocomial pneumonia due to carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae: a propensity score-matched cohort study. Antibiotics. 2023;12(2):273. doi:10.3390/antibiotics12020273
   Google Scholar
• Pavel S, Jitka R. Pharmacokinetics of colistin during extracorporeal membrane oxygenation. J Antimicrob Chemother. 2022;77(8):2298–2300. doi:10.1093/jac/dkac163
   PubMed Web of Science ®Google Scholar
• Brinkmann A, Röhr AC, Köberer A, et al. Therapeutisches Drug Monitoring und individualisierte Dosierung von Antibiotika bei der Sepsis [Therapeutic drug monitoring and individual dosing of antibiotics during sepsis: modern or just “trendy”?]. Med Klin Intensivmed Notfmed. 2018;113(2):82–93. German. doi:10.1007/s00063-016-0213-5
   PubMedGoogle Scholar
• Kühn D, Metz C, Seiler F, et al. Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study. Crit Care. 2020;24(1):664. doi:10.1186/s13054-020-03397-1
   PubMed Web of Science ®Google Scholar
• Dalhoff K, Abele-Horn M, Andreas S, et al. S3-Leitlinie der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin e.V., der Deutschen Gesellschaft für Infektiologie e.V., der Deutschen Gesellschaft für Hygiene und Mikrobiologie e.V., der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V., der Paul-Ehrlich Gesellschaft für Chemotherapie e.V, der Deutschen Röntgengesellschaft und der Gesellschaft für Virologie[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia - update 2017 - S3 guideline of the German society for anaesthesiology and intensive care medicine, the German society for infectious diseases, the German society for hygiene and microbiology, the German respiratory society and the Paul-Ehrlich-society for chemotherapy, the German radiological society and the society for virology]. Pneumologie. 2018;72(1):15–63. German. doi:10.1055/s-0043-121734
   PubMedGoogle Scholar
• Abdul-Aziz MH, Roberts JA. Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter? Curr Opin Anaesthesiol. 2020;33:71–82. doi:10.1097/ACO.0000000000000810
   PubMed Web of Science ®Google Scholar